Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · IEX Real-Time Price · USD
0.775
+0.018 (2.35%)
At close: Apr 23, 2024, 4:00 PM
0.693
-0.083 (-10.65%)
After-hours: Apr 23, 2024, 4:27 PM EDT

Tiziana Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Net Income
-15.4-23.42-26.13-9.32-7.93-8.59-9.77
Depreciation & Amortization
0.050.140.090.250.020.010.01
Share-Based Compensation
1.816.0318.61.270.730.711.38
Other Operating Activities
-6.08-4.51-3.891.012.580.341.46
Operating Cash Flow
-19.62-21.76-11.34-6.8-4.6-7.53-6.93
Capital Expenditures
0-0.02-0-00-0-0.05
Acquisitions
-2.680-0.120000
Change in Investments
-1.320.150000-0.29
Investing Cash Flow
-40.13-0.12-00-0-0.34
Share Issuance / Repurchase
00.1375.46010.091.540.61
Debt Issued / Paid
-0.06-0.15-0.111.68000.96
Financing Cash Flow
-0.06-0.0275.351.6810.091.541.58
Exchange Rate Effect
-0.4-1.981.740000
Net Cash Flow
-23.67-21.6663.89-5.125.49-5.99-5.69
Free Cash Flow
-19.62-21.78-11.34-6.8-4.6-7.53-6.97
Free Cash Flow Per Share
-0.19-0.22-0.17-0.10-0.07--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).